共 50 条
- [41] Role of the US Food and Drug Administration in the regulatory management of human listeriosis in the United StatesJOURNAL OF FOOD PROTECTION, 2008, 71 (06) : 1277 - 1286Klontz, Karl C.McCarthy, Patrick V.Datta, Atin R.Lee, Judy O.Acheson, David W. K.Brackett, Robert E.
- [42] WHEELCHAIR SAFETY - ADVERSE REPORTS TO THE UNITED-STATES FOOD-AND-DRUG-ADMINISTRATIONAMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1995, 74 (04) : 308 - 312KIRBY, RLACKROYDSTOLARZ, SA
- [44] The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agentsCLINICAL INFECTIOUS DISEASES, 2002, 34 (06) : 879 - 881Powers, JHRoss, DBBrittain, EAlbrecht, RGoldberger, MJ
- [45] Autologous cultured chondrocytes:: Adverse events reported to the united states food and drug administrationJOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (03): : 503 - 507Wood, JJMalek, MAFrassica, FJPower, JAMohan, AKBloom, ETBraun, MMCoté, TR
- [46] A study of warning letters issued to clinical investigators by the United States Food and Drug AdministrationCLINICAL AND INVESTIGATIVE MEDICINE, 2004, 27 (03): : 129 - 134Bramstedt, KA
- [47] The United States Food and Drug Administration paradigm for the regulation of tissue-engineered productsTISSUE ENGINEERING, 1997, 3 (01): : 109 - 113Eggerman, TLPatterson, AP
- [50] Nonclinical development of radiopharmaceuticals: Regulatory considerations for the United States food ands drug administrationFROM MORPHOLOGICAL IMAGING TO MOLECULAR TARGETING: IMPLICATIONS TO PRECLINICAL DEVELOPMENT, 2004, 48 : 151 - 165Wilson, S